This is an initial analysis of the Federal Health Budget from the Consumers Health Forum of Australia (CHF). There is further detail in the Budget papers that require further appraisal before CHF takes a view on these aspects. We are preparing a more detailed analysis based on further briefings...
This submission into the Availability of new, innovative and specialist cancer drugs in Australia draws on the experiences of our members and consumer representatives in assessing the availability and effectiveness of medicines in Australia, and in particular the operation of the Pharmaceutical...
The definitive goal of this review of the regulatory framework should be the safety and quality of complementary medicines in Australia. Any new framework must carefully balance the risk to consumer safety and consumer choice concerns.
CHF's new CEO; Pharmacy deal in urgent need of new script; Health Minister Ley: 'above all, consumer-focused'; Now co-pay is cremated, time to revive Medicare; Asthma Australia conference; In sickness and in health; Why do I even need this test?; "Frequent flyer" claim shown to be a sick joke...
Nothing about us, without us!;Tackling obesity: Australia wants change; Price Signals and Health Hazards; Federal Government must not send medicines safety checks offshore; Thanks and farewell to Adam; The costs of chronic illness; Would you like to be part of Consumers Shaping Health?; Problems...
The Consumers Health Forum of Australia (CHF) is the national peak body representing the
interests of Australian healthcare consumers. CHF works to achieve safe, quality, timely healthcare
for all Australians, supported by accessible health information and systems. CHF welcomes the...
CHF considers this review to be of critical importance to every Australian health consumer.
Consumers consistently raise with us their concerns about the safety and quality of medicines,
giving details of personal experiences of when the safety regime has failed them. With this in...
The Consumers Health Forum says it is unacceptable that a new review into medicines and medical devices has failed to reflect the vital interest consumers have in this matter.
The past year has proved a time of significant change for Australia’s health consumers and for CHF itself.